Avastin 100mg/4 ml infusion vial
Choose delivery option:
Choose from our selected products for you
Shop ProductsAvastin 100mg/4 ml concentrate for intravenous infusion
Avastin by Roche contains bevacizumab, a biological monoclonal antibody that targets vascular endothelial growth factor (VEGF). It helps inhibit the formation of new blood vessels that support tumour growth. Treatment response varies.
What is Avastin used for?
Bevacizumab is used in selected treatment regimens for cancers such as colorectal, certain non-small cell lung, kidney, ovarian, cervical and liver cancers. Eligibility and treatment combinations depend on the specific diagnosis, prior therapy and locally approved product information. It is not suitable for every cancer or every patient.
Product details
- Brand: Avastin.
- Manufacturer: Roche.
- Active ingredient: bevacizumab.
- Strength: 100 mg in 4 ml.
- Form: concentrate for solution for intravenous infusion.
- Presentation: one vial.
Preparation and administration
The oncology team determines the dose, treatment interval, dilution and infusion rate using the prescribed regimen and manufacturer's instructions. This listing describes the intravenous oncology presentation.
Important precautions
Important risks include bleeding, impaired wound healing, high blood pressure, blood clots, gastrointestinal perforation and protein in the urine. Recent or planned surgery, pregnancy, breastfeeding and other treatments require specialist assessment.
Possible side effects
Possible side effects include raised blood pressure, headache, nosebleeds, changes in taste and skin symptoms. Serious complications can occur. Refer to the product leaflet for complete safety information.
Frequently asked questions
What does this vial contain?
Each 4 ml vial contains 100 mg of bevacizumab.
Can a bevacizumab biosimilar be substituted directly?
Product choice and switching require confirmation by the treating oncology team. This page does not establish local approval, availability or interchangeability of another brand.
Can hair loss occur during treatment?
Side effects depend on the full treatment regimen, including accompanying chemotherapy. Hair changes should be discussed with the oncology team.
How should the vial be stored?
Follow the exact storage and handling instructions on the supplied pack and manufacturer's leaflet.